In vivo, inhibition of SULT2B1b with 3b-hydroxy-5-cholenoic acid promotes CD8+ T cell infiltration to cholesterol-sulfate-producing tumor and sensitizes the tumor to immunotherapy (Tatsuguchi et al., 2022a). Here, CD8A is linked to neoplasm.